Geographic differences in baseline prostate inflammation and relationship with subsequent prostate cancer risk: results from the multinational REDUCE trial

BACKGROUND: Prostate cancer (PC) incidence rates vary 25-fold worldwide. Differences in PSA screening are largely, but not entirely, responsible. We examined geographic differences in prevalence of histologic prostate inflammation and subsequent PC risk. METHODS: 7,000 non-Hispanic white men were en...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Epidemiol Biomarkers Prev
Autors principals: Allott, Emma H., Markt, Sarah C., Howard, Lauren E., Vidal, Adriana C., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Mucci, Lorelei A., Freedland, Stephen J.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6035080/
https://ncbi.nlm.nih.gov/pubmed/29669727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-18-0076
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars